IPO registrations (S-1, F-1) · Registrants
NUVASIVE INC
- SEC CIK
- 1142596 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-03-05, last 2004-05-11; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2004-05-13
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 7475 LUSK BLVD, San Diego, CA 92121
- EIN
- 33-0768598
- EDGAR entity type
- operating
- Insiders and CEO pay
- NUVASIVE INC on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2004-05-05)
- Final price
- $11.00 per share, within the range (424B4 filed 2004-05-13, an initial public offering)
- Shares sold
- 6,500,000
- Gross proceeds
- $71,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NUVA
- Lead underwriters
- BofA Securities (2,502,500 shares); Lehman Brothers (2,502,500 shares); Thomas Weisel Partners (1,170,000 shares); William Blair (325,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: NUVASIVE, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: NUVASIVE, LLC EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: NuVasive, Inc. Fuzzy (name and state)
- Business registration: NUVASIVE, INC. Fuzzy (name and state)
- Business registration: NuVasive, LLC Fuzzy (name and state)
- Business registration: NUVASIVE, LLC Fuzzy (name and state)
- Business registration: NUVASIVE, LLC Fuzzy (name and state)
- Business registration: NUVASIVE, LLC Fuzzy (name and state)
- Form 5500 plan sponsor: NUVASIVE, INC EXACT (EIN (EXACT))
- Federal award recipient: NUVASIVE, INC Fuzzy (name and state)
- SEC filer: NUVASIVE INC EXACT (CIK (EXACT))
- Person page: Amy Belt Raimundo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Lesley H Howe Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Leslie V Norwalk Jd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Michael D O'Halleran Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Mr Matthew K Harbaugh Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Robert F Friel Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-03-05 | S-1 | S-1 (registration) | NUVASIVE INC | 0001047469-04-006806 ↗ |
| 2004-04-08 | S-1/A | S-1/A (amendment) | NUVASIVE INC | 0001047469-04-011386 ↗ |
| 2004-04-26 | S-1/A | S-1/A (amendment) | NUVASIVE INC | 0001047469-04-013393 ↗ |
| 2004-05-05 | S-1/A | S-1/A (amendment) | NUVASIVE INC | 0001047469-04-015702 ↗ |
| 2004-05-11 | S-1/A | S-1/A (amendment) | NUVASIVE INC | 0001047469-04-016818 ↗ |
| 2004-05-13 | 424B4 | 424B4 (final prospectus) | NUVASIVE INC | 0001047469-04-017088 ↗ |
| 2005-08-29 | 424B1 | 424B1 (final prospectus) | NUVASIVE INC | 0001104659-05-041813 ↗ |
| 2005-09-08 | 424B1 | 424B1 (final prospectus) | NUVASIVE INC | 0001104659-05-043382 ↗ |
| 2006-02-02 | 424B4 | 424B4 (final prospectus) | NUVASIVE INC | 0001193125-06-018213 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-05-05 | S-1/A | registration statement | $11.00–$13.00 | 6,500,000 | - | Nasdaq NUVA | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2004-05-11 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2004-05-13 | 424B4 | final prospectus | $11.00 | 6,500,000 | $71,500,000 | Nasdaq NUVA | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Cornwall G Bryan | Officer | VP, Research & Development | 14 | 2006 | |
| Hannon Jason | Officer | EVP and General Counsel; EVP, Gen. Counsel & Secretary; EVP, General Counsel & Sec.; EVP, International; EVP, Int'l and General Counsel; President and COO; SVP and General Counsel; VP, Legal Affairs; VP, Legal Affairs & Secretary | 82 | 2006–2017 | |
| Lukianov Alexis V | Director,Officer | CEO and Chairman; Chairman & CEO; Chief Exec. Officer & Chairman | 86 | 2006–2015 | |
| Miles Patrick | Director; Officer | EVP, Marketing and Development; Pres., Global Products & Svcs; President, Americas; President and COO; President, Global Prod & Svcs; Senior VP, Marketing | 95 | 2006–2017 | |
| OBOYLE KEVIN C | Officer | CFO and Executive VP | 50 | 2006–2009 | |
| Skinner James J | Officer | VP,Strategic Sales Development | 9 | 2006 | |
| Spangler Jonathan | Officer | VP & Chief Patent Counsel | 10 | 2006 | |
| Valentine Keith | Officer | COO; Pres. & Chief Operating Office; President; President and COO; President & COO | 89 | 2006–2015 | |
| Yuan Hansen A | Director | 9 | 2006–2009 | ||
| BLAIR JACK R | Director | 22 | 2006–2016 | ||
| FARRELL PETER C | Director | 20 | 2006–2018 | ||
| HOWE LESLEY H | Director | 26 | 2006–2018 | person page Fuzzy | |
| HUNT ROBERT J | Director | 19 | 2006–2014 | ||
| BLAIR JAMES C | Director | 8 | 2006–2007 | ||
| Rydin Jeffrey P | Officer | EVP, Sales, Americas; President, Global Sales; Senior V.P., U.S. Sales | 39 | 2007–2012 | |
| MORE EILEEN M | Director | 17 | 2007–2014 | ||
| Treharne Richard III | Director | 11 | 2009–2013 | ||
| LAMBERT MICHAEL | Officer | CFO and Executive VP; EVP & CFO; Executive Vice Pres. & CFO | 25 | 2009–2014 | |
| Hunsaker Craig E | Officer | SVP, Global Human Resources | 26 | 2011–2014 | |
| Lipschultz Tyler | Officer | EVP, Biologics; Exec. VP., Global Operations | 6 | 2011–2012 | |
| Leddy Peter Michael | Director; Officer; Other | EVP Corp Integrity and HR; EVP Global HR; EVP, People and Culture | 14 | 2011–2019 | |
| Link Matthew | Officer | EVP, Strategy, Tech & Corp Dev; EVP, U.S. Sales; Exec. VP U.S. Sales; President; President, Strat/Tech/Corp Dev; President, U.S. Commercial; President, U.S. Sales and Svc. | 45 | 2013–2020 | |
| Powers Russell | Officer | EVP; EVP, International; Exec. VP Sales Int'l Ops | 28 | 2013–2015 | |
| LUCIER GREGORY T | Director; Director,Officer | Chairman & CEO | 38 | 2013–2021 | |
| Paolucci Michael E | Officer | EVP, Global Human Resources; Exec. V.P., Global HR | 4 | 2014 | |
| Norwalk Leslie V | Director | 14 | 2014–2023 | person page Fuzzy | |
| Blackford Quentin S. | Officer | CFO; CFO and CAO | 14 | 2014–2017 | |
| Carol Cox | Officer; Other | EVP, Corporate Affairs and HR; EVP Ext Affairs & Corp Mktg; EVP External Affairs; EVP Strategy, Corp Dev | 10 | 2014–2019 | |
| CAPPS VICKIE L | Director | 12 | 2015–2023 | ||
| Wolterman Dan | Director | 11 | 2015–2023 | ||
| Hanson Jason David | Officer | EVP, Strategy, Corp Dev & GC | 1 | 2015 | |
| FRIEL ROBERT F | Director | 11 | 2016–2023 | person page Fuzzy | |
| Rosenberg Donald J | Director | 11 | 2016–2022 | ||
| Roschak Edmund J | Officer | CEO, NuVasive Spec. Orthopedic | 2 | 2016–2017 | |
| OHALLERAN MICHAEL D | Director | 10 | 2016–2019 | person page Fuzzy | |
| Sylvain Jereme M | Officer | Chief Accounting Officer | 5 | 2016–2018 | |
| Stafslien Joan | Officer; Other | EVP and General Counsel | 4 | 2016–2019 | |
| KIIL HARRY SKIP | Officer | EVP International | 1 | 2017 | |
| Rozow Stephen | Officer | EVP, Global Process | 2 | 2017–2018 | |
| Asarpota Rajesh | Officer | CFO | 4 | 2017–2019 | |
| DeFord John A | Director | 9 | 2018–2023 | ||
| SISITSKY NATHANIEL | Officer | SVP & General Counsel | 13 | 2018–2023 | |
| Huennekens R Scott | Director | 8 | 2018–2023 | ||
| Barry James Christopher | Director,Officer | Chief Executive Officer | 17 | 2018–2023 | |
| McClintock Paul | Officer | President, U.S. Commercial | 4 | 2019 | |
| Vitale Lucas | Officer | Chief Human Resources Officer | 11 | 2019–2021 | |
| Harbaugh Matthew K | Officer | EVP and CFO | 8 | 2020–2023 | person page Fuzzy |
| Wolf Dale A. | Officer | SVP, Global Operations | 8 | 2020–2023 | |
| Boucher Brent J. | Officer | EVP, Global Commercial | 3 | 2020–2021 | |
| Calafiore Massimo | Officer | EVP, Chief Commercial Officer; EVP, Global Business Units | 9 | 2020–2022 | |
| Kadia Siddhartha | Director | 7 | 2021–2023 | ||
| Raimundo Amy Belt | Director | 5 | 2021–2023 | person page Fuzzy | |
| Morton Andrew C. | Officer | SVP, CHRO | 2 | 2022 | |
| Rosenbaum Marc W. | Officer | Chief Accounting Officer | 2 | 2022–2023 | |
| Farrington Michael | Officer | SVP, People and Culture | 3 | 2022–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NuVasive, Inc. | CA | State business registries | name and state |
| Business registration | NUVASIVE, INC. | CA | State business registries | name and state |
| Business registration | NuVasive, LLC | CA | State business registries | name and state |
| Business registration | NUVASIVE, LLC | CA | State business registries | name and state |
| Business registration | NUVASIVE, LLC | CA | State business registries | name and state |
| Business registration | NUVASIVE, LLC | CA | State business registries | name and state |
| Business registration | NUVASIVE, LLC | CA | State business registries | name and state |
| Plan sponsor | NUVASIVE, INC | CA | Form 5500 (employee benefit plans) | name and state |
| Plan sponsor | NUVASIVE, INC | CA | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | NUVASIVE, INC | CA | Federal spending (USAspending) | name and state |
| Paying company | NuVasive, Inc. | CA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | NuVasive, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | NUVASIVE INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NuVasive, Inc. | CA | Trademarks (USPTO) | name and state |
| Business registration | NUVASIVE, INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | NUVASIVE, INC | EIN (EXACT) | ||
| Person page | Amy Belt Raimundo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Lesley H Howe | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Leslie V Norwalk Jd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Michael D O'Halleran | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Mr Matthew K Harbaugh | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Robert F Friel | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.